• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Emergent Biosolutions Inc

+ Add to Watchlist

EBS:US

22.6100 USD 0.0300 0.13%

As of 20:04:08 ET on 07/21/2014.

Company Profile for Emergent Biosolutions Inc (EBS)

Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.

Contact Information

Emergent Biosolutions Inc

2273 Research Boulevard
Suite 400
Rockville, MD 20850
United States
Phone: 1-301-795-1800
Fax: 1-301-795-1899

Key Executives for Emergent Biosolutions Inc (EBS)

Fuad El-HibriChairmanDaniel J Abdun-NabiPresident/CEO
Adam HaveyExec VP/President:BiodefenseBarry A LabingerExec VP/Pres:Biosciences Div
Anatolio B Cruz IIIExec VP/Gen Cnsl/SecretaryRobert G Kramer SrExec VP:Corporate Services/CFO
Scott C StromattSenior VP/Chief Medical OfficerRobert G Burrows "Bob"VP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil